You will find our proxy statement and our Annual Report on Form 10-K below. After reviewing these materials, if you are a registered holder of shares of Theravance Biopharma, Inc., you may vote your shares via the internet at http://www.investorvote.com/TBPH or on the telephone by calling 1-800-652-8683. In order to vote, you will need to have in-hand information from the proxy card that will be mailed to you, along with the Annual Report and proxy statement, on or around March 27, 2018. If you are a beneficial holder of shares of Theravance Biopharma, Inc. (for example, your shares are held in an account at an institution such as a brokerage firm, bank, dealer, or other similar organization), please follow the voting instructions provided by your institution. If you are a beneficial holder, your shares will not be voted by your institution with respect to non-discretionary items, in other words, all proposals other than Proposal 2, without direction from you pursuant your institution's instructions.
Theravance Biopharma Proxy Statement
Theravance Biopharma Form 10-K